Is Hormone Replacement Therapy Safe and What to Know

Hormone replacement therapy (HRT) is generally safe for healthy women under age 60, or those within 10 years of menopause onset, when the benefits of symptom relief and bone protection typically outweigh the risks. The U.S. Food and Drug Administration (FDA) updated its guidance on HRT in November 2025, removing the black box warning from certain hormone therapy products after reviewing more than two decades of new evidence. Safety depends on several personal factors, including your age, health history, the type of hormones used, and the delivery method. This blog covers what makes HRT safe for some people, what the real risks are, how different forms of hormone therapy compare, and how to know if hormone replacement therapy is the right choice for you.

What Is Hormone Replacement Therapy and How Does It Work?

Hormone replacement therapy is a medical treatment that replaces estrogen, progesterone, or both hormones that the body stops producing in adequate amounts during menopause. Estrogen is the primary hormone involved in HRT because declining estrogen levels cause the majority of menopause symptoms. Progesterone is added when a woman still has her uterus, because estrogen taken alone can cause the uterine lining to thicken and raise the risk of endometrial cancer.

The two main types of HRT are estrogen-only therapy and combination therapy. Estrogen-only therapy works best for women who have had a hysterectomy. Combination therapy pairs estrogen with a progestogen, which is a group of progesterone-like hormones that protect the uterus. According to StatPearls, HRT is FDA-approved to treat severe vasomotor menopausal symptoms and to prevent osteoporosis in postmenopausal women.

HRT also comes in two broad categories based on how the hormones enter the body. Systemic hormone therapy delivers hormones into the bloodstream through pills, skin patches, gels, sprays, or injections. Systemic therapy treats hot flashes, night sweats, sleep disturbances, and mood changes across the whole body. Local hormone therapy applies low-dose estrogen directly to the vaginal area through creams, rings, or tablets. Local therapy treats vaginal dryness and urinary symptoms without sending large amounts of estrogen through the bloodstream.

What Is the Safest Form of Hormone Replacement Therapy?

The safest form of hormone replacement therapy is low-dose transdermal estrogen, delivered through a skin patch, gel, or spray, combined with micronized progesterone for women who still have a uterus. Transdermal estrogen bypasses the liver entirely, which avoids the increased clotting-factor production that oral estrogen triggers. This liver bypass is what makes patches and gels carry a lower risk of blood clots and stroke compared to pills.

Micronized progesterone, sometimes sold under the brand name Prometrium, has a safer profile than older synthetic progestins like medroxyprogesterone acetate (MPA). Research published in the journal Climacteric found that micronized progesterone does not carry the same breast cancer risk increase that MPA showed in the Women's Health Initiative (WHI) trial. The route of delivery matters just as much as the type of hormone prescribed. A low-dose vaginal estrogen cream or ring is the safest option for women whose primary symptoms are vaginal dryness and urinary discomfort, because the estrogen stays local and barely enters the bloodstream.

The safest form of HRT also depends on what your body specifically needs. We always recommend comprehensive hormone testing before starting any form of therapy, because the right type and dose of hormones varies from person to person. A treatment that works well for one woman may not be the best fit for another.

What Are the Benefits of Hormone Replacement Therapy?

The benefits of hormone replacement therapy include relief from hot flashes and night sweats, improved bone density, better sleep, mood stabilization, reduced vaginal dryness, and a lower risk of osteoporotic fractures. Estrogen is the single most effective treatment for vasomotor symptoms like hot flashes. The North American Menopause Society and the FDA both recognize HRT as a first-line treatment for moderate to severe menopause symptoms.

Bone protection is one of the strongest long-term benefits of HRT. Postmenopausal osteoporosis affects roughly 1 in 3 women, according to a review published in Best Practice and Research Clinical Endocrinology and Metabolism. HRT reduces fracture risk at all bone sites by 20-40%, according to meta-analyses cited by the International Osteoporosis Foundation. A study presented at ENDO 2026 found that women on menopausal hormone therapy were 69% less likely to have low bone mineral density compared to non-users.

HRT also shows metabolic benefits. A 2024 retrospective cohort study of 6,566 participants, cited in StatPearls, found that HRT was associated with a lower incidence of diabetes over 20 years, with a hazard ratio of 0.693. Peri-menopausal and early postmenopausal women are 2 to 4 times more likely to experience a major depressive episode, according to research published in Frontiers in Reproductive Health. Estrogen supplementation in early postmenopause has been associated with reductions in depressive symptoms, with transdermal estradiol showing the most consistent mood benefits.

What's the Downside to Hormone Replacement Therapy?

The downside to hormone replacement therapy is that it can increase the risk of blood clots, stroke, breast cancer with long-term combination use, and endometrial cancer when estrogen is taken alone without a progestogen. These risks are real, but they are not equal for every person. The actual level of risk depends on your age, health history, the type of hormone used, and the route of delivery.

The WHI trial, which included 27,347 postmenopausal women ages 50 to 79, found 8 additional invasive breast cancers per 10,000 women-years in the combination HRT group. That translates to an absolute risk increase of roughly 0.08% per year, according to a 2024 analysis published in the GREM Journal. The WHI 20-year follow-up data, published in May 2024, showed no increase in deaths from breast cancer or cardiovascular disease among trial participants, according to Stanford Lifestyle Medicine. The estrogen-only arm of the WHI actually showed a reduction in breast cancer rates.

The key to managing these risks is starting HRT at the right time, using the lowest effective dose, choosing the safest delivery method, and monitoring hormone levels regularly. We approach hormone therapy with a root-cause perspective, which means we test thoroughly before prescribing and we track progress over time to keep the risk-benefit balance in your favor.

Can Hormone Replacement Therapy Cause Blood Clots?

Yes, hormone replacement therapy can cause blood clots, but the risk depends heavily on whether the hormones are taken by mouth or applied through the skin. Oral estrogen passes through the liver, where it stimulates the production of clotting factors. This liver-first metabolism is what creates the elevated clot risk with pills. Transdermal estrogen, delivered through a patch or gel, enters the bloodstream directly and does not trigger the same clotting response.

The WHI found that oral combination HRT caused 10 additional pulmonary embolisms per 10,000 women-years and 7 additional coronary heart disease events per 10,000 women-years. Women with existing risk factors for blood clots, such as a history of deep vein thrombosis (DVT), obesity, or a clotting disorder, should discuss transdermal options with their provider. The clot risk is one of the primary reasons we prioritize comprehensive testing before starting any hormone protocol.

How Does HRT Affect Your Heart?

HRT affects your heart differently depending on when you start it. The timing hypothesis, supported by multiple studies and now reflected in updated FDA guidance, shows that women who begin HRT before age 60 or within 10 years of menopause face no increased cardiovascular risk. Women who delay HRT beyond this window face higher risk, because arteries that have already developed plaque respond differently to estrogen than healthy arteries.

Women who lose estrogen before age 40 through early menopause or surgical removal of the ovaries face increased cardiovascular risk if they do not replace estrogen. For these women, HRT is protective, not harmful. The cardiovascular picture is not one-size-fits-all, and we evaluate each patient's full metabolic and vascular profile before recommending therapy.

Is Hormone Replacement Therapy Safe for Men?

Hormone replacement therapy is safe for most men with clinically low testosterone levels when prescribed and monitored properly. Male HRT, commonly called testosterone replacement therapy (TRT), replaces testosterone that the body no longer produces in adequate amounts due to aging, medical conditions, or gland dysfunction. Symptoms of low testosterone in men include fatigue, reduced muscle mass, increased body fat, low libido, depressed mood, and brain fog.

The TRAVERSE trial, a large clinical trial led by researchers at the Cleveland Clinic, found that testosterone replacement did not raise the incidence of heart attack, stroke, or heart-related death in men with both heart problems and hypogonadism. This trial directly addressed the longstanding concern that TRT increases cardiovascular risk. TRT is delivered through injections, topical gels, patches, or pellets. The primary safety considerations for men on TRT include monitoring red blood cell counts, because testosterone can stimulate overproduction of red blood cells, and regular prostate screening, because testosterone may stimulate growth in existing prostate cancer cells.

We work with men experiencing andropause, the gradual decline in testosterone that typically begins after age 30 and accelerates after age 50. Comprehensive testing, including serum testosterone, free testosterone, sex hormone-binding globulin (SHBG), and metabolic markers, guides our protocols for safe, effective hormone optimization in men.

Is Bioidentical Hormone Therapy Safer Than Synthetic?

Bioidentical hormone therapy uses hormones that are molecularly identical to the estrogen, progesterone, and testosterone the human body produces naturally, and emerging evidence suggests bioidentical formulations carry a more favorable safety profile than older synthetic alternatives. The distinction matters because molecular structure determines how a hormone binds to receptors and how the body metabolizes it. Synthetic hormones like conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) differ structurally from human hormones, which is why they produce different metabolic effects.

Several FDA-approved bioidentical hormone therapy options exist, including micronized 17-beta estradiol and micronized progesterone. Compounded bioidentical hormones, which are custom-mixed at specialty pharmacies, are also available but are not FDA-regulated and lack the same standardized testing for potency and purity. The Cleveland Clinic notes that compounded hormones are not well-studied and many providers do not recommend them.

We use functional medicine principles to select the specific bioidentical formulation that matches each patient's lab results, symptom profile, and health history. Patients at our Bingham Farms, Michigan practice benefit from comprehensive testing that guides every hormone therapy decision. The table below compares the three main categories of hormone therapy.

FeatureFDA-Approved BioidenticalSynthetic HormonesCompounded BioidenticalMolecular StructureIdentical to human hormonesStructurally different from human hormonesIdentical to human hormonesFDA RegulationYes, fully regulatedYes, fully regulatedNo, pharmacy-regulated onlyStandardized DosingYesYesNo, custom-mixed per prescriptionBreast Cancer RiskLower with micronized progesteroneHigher with MPA per WHI dataInsufficient long-term dataBlood Clot RiskLower with transdermal deliveryHigher with oral CEEVaries by formulationDelivery MethodsPatches, gels, pills, creamsPills, patches, injectionsCreams, troches, capsules, pellets

The differences in breast cancer risk and blood clot risk between these categories are well-documented. Data from the WHI clinical trials showed that synthetic MPA raised breast cancer risk more than micronized progesterone, while the North American Menopause Society's 2022 position statement confirmed that transdermal delivery lowers clot risk compared to oral estrogen across all categories. Compounded formulations remain the least studied of the three, which is why the Cleveland Clinic advises caution with custom-compounded hormones that lack FDA standardization.

Is Natural Hormone Replacement Therapy Safe?

Natural hormone replacement therapy is safe when it refers to FDA-approved bioidentical hormones derived from plant sources like soy and wild yam, but "natural" does not automatically mean safer or unregulated. The term "natural" can be misleading. All FDA-approved bioidentical hormones start as plant compounds that are then processed in a laboratory to match human hormone structure exactly. The plant origin does not change the fact that they are still pharmaceutical hormones that require medical supervision.

Some women explore phytoestrogens, which are plant-based compounds found in soy, flaxseed, and red clover that weakly mimic estrogen in the body. A 2025 systematic review on bone health in postmenopausal women found that soy isoflavones reduced bone resorption markers by 11.38% over one year, compared to a 15.32% reduction with HRT. Phytoestrogens may offer mild symptom relief for women who cannot or prefer not to take prescription HRT, but they do not match the potency or clinical evidence behind FDA-approved hormone therapy.

We take an integrative approach to hormone health through naturopathic medicine. For some patients, supporting hormone balance through targeted nutrition, stress management, adaptogenic herbs, and lifestyle modification can complement or sometimes replace prescription HRT. For others, bioidentical hormones combined with these natural strategies produce the best results.

What Are Signs a Woman Needs HRT?

Signs a woman needs HRT include frequent hot flashes, night sweats that disrupt sleep, persistent vaginal dryness, unexplained mood swings, difficulty concentrating, and early bone density loss. These symptoms result from declining estrogen levels during perimenopause and menopause. Not every woman experiences them with the same severity. Some women move through menopause with minimal discomfort, while others find that symptoms significantly affect their daily life.

Other signs that point toward hormone imbalance include chronic fatigue that does not improve with rest, painful intercourse due to vaginal tissue thinning, recurrent urinary tract infections, joint stiffness, thinning hair, and increased anxiety or depressive episodes. A hormonal imbalance can also show up as stubborn weight gain around the midsection, because estrogen decline shifts fat storage patterns toward visceral fat accumulation.

The only way to confirm whether symptoms are caused by hormone deficiency is through lab testing. We use comprehensive panels that measure estradiol, progesterone, testosterone, DHEA-S, cortisol, thyroid hormones, and key metabolic markers. Testing removes the guesswork and allows us to match each patient with the specific type and dose of hormone therapy that addresses their individual imbalance.

What Disqualifies You From HRT?

A history of hormone-sensitive cancers, blood clots, active liver disease, undiagnosed vaginal bleeding, or a recent stroke or heart attack can disqualify you from hormone replacement therapy. These contraindications exist because HRT can worsen certain conditions or interact with ongoing treatments. The following conditions typically disqualify someone from starting HRT:

• Active or recent hormone receptor-positive breast, ovarian, or endometrial cancer
• History of blood clots, deep vein thrombosis (DVT), or pulmonary embolism
• Active liver disease or severely impaired liver function
• Undiagnosed abnormal vaginal bleeding
• Recent heart attack, stroke, or known cardiovascular disease with elevated risk
• Pregnancy or suspected pregnancy

Women with a history of estrogen receptor-positive (ER+) breast cancer face the highest restriction. The American Cancer Society explains that HRT adds hormones to the body that can interfere with cancer treatments designed to block hormone receptors. However, a personal history of HR+ breast cancer does not always permanently disqualify someone from HRT. Oncologists evaluate the type, stage, and grade of the cancer, how long ago it was treated, and the severity of menopause symptoms before making a final decision.

A 2024 UK study of 182,589 women with 17 different cancer types (excluding breast cancer) found that 7% used systemic HRT after diagnosis, and the results showed no evidence of increased cancer-specific mortality among HRT users compared to non-users, according to StatPearls. This finding suggests that HRT may be safer than previously assumed for survivors of many non-breast cancers, though individual evaluation remains essential.

Why Do Doctors Discourage HRT?

Some doctors discourage HRT because of lingering concerns from the WHI trial published in 2002, which initially linked combination hormone therapy to increased risks of breast cancer and cardiovascular events. The WHI trial was stopped early and generated widespread fear about HRT that shaped medical practice for more than two decades. Many physicians trained during that era adopted a cautious stance that persists today.

The context matters. The WHI trial enrolled women with an average age of 63, which is well past the window where HRT provides the greatest benefit and lowest risk. The hormones used were oral conjugated equine estrogens and synthetic medroxyprogesterone acetate, not the bioidentical transdermal formulations that are now standard. The 20-year follow-up data published in May 2024 showed no increase in all-cause mortality among women who started HRT under age 60, according to researchers at Stanford.

The FDA's decision to remove the black box warning from certain HRT products in November 2025 reflects this updated evidence. The agency convened an expert panel in July 2025 to reassess HRT safety, and the panel concluded that the benefit-risk profile is more favorable than the original black box warning communicated. Doctors who stay current with the evidence now view HRT as a valuable option for the right patient at the right time.

What Age Is Too Late to Take Estrogen?

Starting estrogen after age 60, or more than 10 years after menopause, carries higher risks and is generally not recommended for new HRT initiation. This timing guideline comes from the consistent finding across multiple studies that early initiation of HRT is protective, while late initiation can be harmful. The reason relates to vascular health. Younger, healthier arteries respond well to estrogen. Older arteries that have already accumulated plaque can respond poorly, increasing the risk of cardiovascular events.

Women who go through early menopause or have their ovaries removed before age 45 are an important exception. These women benefit from HRT started immediately and continued at least until the average age of natural menopause, which is 51. Without estrogen replacement, early menopause accelerates bone loss, cardiovascular risk, and cognitive decline. Bone mineral density declines approximately 1-2% per year for the first 3 to 5 years after menopause onset, then 0.5-1% per year after that, according to data from the National Institutes of Health.

Should a 50 Year Old Woman Take Estrogen?

Yes, a 50 year old woman is within the optimal window to start estrogen therapy, provided she has bothersome menopause symptoms and no contraindications. Age 50 falls squarely within the "under 60 or within 10 years of menopause" guideline that the FDA, Mayo Clinic, Cleveland Clinic, and the North American Menopause Society all support. At this age, the cardiovascular, bone, and metabolic benefits of HRT are strongest, and the risks are lowest.

What Are the Risks of HRT After 60?

The risks of HRT after 60 include a higher chance of blood clots, stroke, and cardiovascular complications compared to starting HRT in the 50s. Women who begin HRT after age 60 or more than a decade past menopause showed increased risk of serious complications in the WHI and subsequent studies. For women already on HRT who turn 60, the decision to continue should be made with their provider through regular reassessment of the benefit-risk balance.

How Long Should You Stay on Hormone Replacement Therapy?

Most women stay on hormone replacement therapy for five years or less, though some women benefit from longer use depending on symptom severity, bone health needs, and individual risk factors. There is no universal stop date. The Cleveland Clinic advises that the duration of HRT should be individualized and reevaluated regularly by your provider.

Women with early menopause typically stay on HRT longer because they need estrogen replacement until at least the average age of natural menopause. Women who start HRT at the typical menopause age for symptom relief may use it for 3-5 years and then gradually taper under medical supervision. The tapering process matters because stopping HRT abruptly can cause symptoms to return. At our Michigan practice, we monitor hormone levels, symptom response, and risk markers at regular intervals to guide ongoing treatment decisions.

Annual reassessment includes repeat lab work, bone density screening when appropriate, breast cancer screening, and a conversation about whether the benefits of continuing HRT still outweigh the risks. Nutrition and weight management support alongside HRT helps patients maintain results even after stepping down their hormone dose.

What Happens If You Don't Take Estrogen in Menopause?

If you don't take estrogen in menopause, your body continues to lose bone density, vaginal tissue thins, cardiovascular risk rises, and symptoms like hot flashes and sleep disruption may persist for years. Not every woman needs HRT. But the consequences of untreated estrogen deficiency are measurable and cumulative.

Bone loss is the most quantifiable consequence. Postmenopausal women without HRT lose bone density at a rate of 1-2% per year for the first 3-5 years after menopause. Over a decade, this loss compounds into significant osteoporosis risk. The International Osteoporosis Foundation reports that HRT is the only anti-osteoporotic therapy with proven fracture-reduction efficacy regardless of baseline risk level.

Vaginal atrophy, now called genitourinary syndrome of menopause (GSM), is another progressive consequence. Without estrogen, vaginal tissue loses elasticity, lubrication, and thickness over time. GSM does not resolve on its own and typically worsens without treatment. Mental health effects are also significant, as estrogen influences serotonin, dopamine, and norepinephrine production in the brain.

Do You Age Quicker Without HRT?

Yes, estrogen deficiency accelerates several markers of biological aging, including bone density loss, skin collagen decline, cardiovascular changes, and cognitive slowing. Estrogen plays a direct role in collagen synthesis, vascular elasticity, and neuronal protection. Without it, these systems decline faster than they would in a premenopausal state. This does not mean every woman needs HRT to age well, but it does mean that untreated estrogen deficiency has measurable effects on the body's aging process.

Is There a Link Between HRT and Dementia?

The link between HRT and dementia depends on when hormone therapy starts. Early initiation of HRT, during perimenopause or within the first few years of menopause, appears to be neuroprotective. Late initiation, particularly after age 65, has shown mixed or potentially negative cognitive effects in some studies. The 2024 Lancet Commission on dementia reported that the evidence remains unclear on whether menopause and HRT are causally related to dementia risk, but acknowledged that timing of initiation is a critical variable.

Do You Lose Weight After Starting HRT?

Some women do lose weight after starting HRT, particularly visceral belly fat, because estrogen helps regulate fat distribution, insulin sensitivity, and metabolic rate. Estrogen deficiency shifts the body's fat storage pattern from the hips and thighs toward the abdomen. Replacing estrogen can reverse this shift over time. HRT also improves insulin sensitivity, which makes it easier for the body to use glucose for energy instead of storing it as fat.

HRT alone is not a weight loss treatment. The women who see the best body composition improvements combine hormone optimization with targeted nutrition, regular physical activity, and stress management. We see this regularly in our practice, where weight gain related to hormonal imbalance responds to an integrative protocol that addresses the root causes rather than just the symptoms.

Does HRT Help With Belly Fat?

Yes, HRT can help reduce belly fat because estrogen directly influences where the body stores fat. During menopause, declining estrogen levels cause an increase in visceral adipose tissue, which is the deep abdominal fat that wraps around internal organs. Visceral fat is metabolically active and raises the risk of insulin resistance, type 2 diabetes, and cardiovascular disease. Restoring estrogen levels through HRT shifts fat storage away from the visceral compartment. The metabolic improvement is most pronounced when HRT is combined with exercise and dietary changes that support insulin sensitivity.

What Are the First Signs of Estrogen Working?

The first signs of estrogen working are improved sleep quality and a reduction in night sweats, which most women notice within 2 to 4 weeks of starting HRT. Symptom improvements follow a general timeline, though individual responses vary based on the type, dose, and delivery method of hormone therapy prescribed.

1. Sleep quality and night sweats improve within 2 to 4 weeks as estrogen stabilizes the body's thermoregulation system.
2. Hot flash frequency and intensity decrease within 4 to 8 weeks of consistent therapy.
3. Mood stabilization, reduced anxiety, and better concentration emerge within 4 to 8 weeks as estrogen influences serotonin and dopamine activity in the brain.
4. Vaginal dryness and discomfort during intercourse resolve gradually over 8 to 12 weeks of local or systemic estrogen therapy.
5. Skin hydration and elasticity improve over 3 to 6 months as estrogen stimulates collagen production.
6. Bone density improvements become measurable on DEXA scans after 12 months of continuous treatment.

We track progress through follow-up testing and symptom surveys at regular intervals to confirm that the therapy is working as expected and to adjust dosing when needed.

Is It Healthier to Go Through Menopause Without HRT?

Going through menopause without HRT is healthier for women who have contraindications like a history of hormone-sensitive cancer or blood clots, but it is not necessarily healthier for women with moderate to severe symptoms and no risk factors. The idea that menopause is a natural process that should not require medical intervention ignores the measurable health consequences of estrogen deficiency.

For women with mild symptoms and no bone density concerns, lifestyle strategies like regular weight-bearing exercise, a nutrient-dense diet, stress reduction, and adequate sleep can effectively manage the menopause transition. Thyroid issues and adrenal dysfunction should also be evaluated, because these conditions mimic menopause symptoms and require different treatment.

For women with disruptive hot flashes, severe sleep disturbance, rapid bone loss, or significant mood changes, withholding HRT when no contraindication exists means accepting preventable health decline. The decision is personal, and it should be informed by testing, not by fear left over from outdated interpretations of the WHI data. For women who do choose hormone optimization, working with a provider who tests thoroughly and monitors consistently makes all the difference.

Frequently Asked Questions

Do You Age Faster Without Estrogen?

Yes, you age faster without estrogen in several measurable ways. Bone density declines at 1-2% per year in the first 3-5 years of menopause. Skin collagen production drops by approximately 30% in the first five years after menopause, according to dermatological research. Cardiovascular aging accelerates as estrogen's protective effect on blood vessel elasticity diminishes. These changes are cumulative and progressive without hormone replacement.

How Safe Is Hormone Replacement Therapy?

Hormone replacement therapy is safe for the majority of healthy women who start it before age 60 or within 10 years of menopause. The absolute risk increase for breast cancer with combination HRT is approximately 0.08% per year, or 8 additional cases per 10,000 women-years, according to WHI data. The FDA's November 2025 labeling update reflects the medical consensus that benefits outweigh risks for appropriately selected patients.

Can HRT Be Combined With Other Treatments?

Yes, HRT works well in combination with other treatments. Naturopathic support through targeted nutrition, adaptogenic herbs, stress management, and detoxification protocols can amplify the benefits of hormone replacement. Cognitive behavioral therapy can complement HRT for managing mood and sleep symptoms. Exercise, particularly resistance training and weight-bearing activity, enhances the bone-protective effects of estrogen therapy.

What Tests Should You Get Before Starting HRT?

Before starting HRT, you should get a comprehensive hormone panel that includes estradiol, progesterone, testosterone, DHEA-S, cortisol, and a full thyroid panel (TSH, free T3, free T4, thyroid antibodies). Metabolic markers like fasting insulin, glucose, and a lipid panel help assess cardiovascular and metabolic baseline risk. Bone density screening (DEXA scan) establishes a baseline for tracking the skeletal benefits of therapy. Mammography and a pelvic exam should be current before initiating treatment.

How Often Should HRT Be Monitored?

HRT should be monitored with follow-up lab work at 6-8 weeks after starting, then every 6-12 months depending on the individual. Annual mammograms, blood pressure checks, and symptom reassessments are standard during HRT use. Bone density scans are repeated every 1-2 years for women using HRT primarily for osteoporosis prevention. Monitoring ensures that the dose remains appropriate and that no new risk factors have developed.

Putting It All Together

Hormone replacement therapy is safe for most people when it is started at the right time, prescribed in the right form, and monitored properly. The science has evolved significantly since the early WHI findings created widespread hesitation. Updated evidence, including 20-year follow-up data and the FDA's 2025 labeling changes, supports HRT as an effective and evidence-backed option for managing menopause symptoms, protecting bones, and supporting metabolic and cardiovascular health.

The most important step is getting tested before making any decision. Comprehensive lab work reveals exactly what your body needs and guides a protocol that is specific to you. At Cutler Integrative Medicine, we combine advanced diagnostic testing with naturopathic and integrative therapies to help patients achieve lasting hormone balance. If you have questions about whether HRT is right for you, we are here to help you find answers. You can reach us at (248) 663-0165 to schedule a consultation.